Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta‐analysis

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

(2019) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of drugs on venous thromboembolism risk in surgical patients

(2019) Alenka Premuš Marušič Kovačič et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Periprocedural Bridging Anticoagulation: Measuring the Impact of a Clinical Trial on Care Delivery

(2018) Geoffrey D. Barnes et al.   AMERICAN JOURNAL OF MEDICINE

2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

(2017) John U. Doherty et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

(2017) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

New anticoagulants, why are they different

(2016) Sam Schulman   PATHOLOGY

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

(2015) James D. Douketis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure

(2015) Jeff S. Healey et al.   THROMBOSIS AND HAEMOSTASIS

Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures

(2015) Nathan P. Clark et al.   JAMA Internal Medicine

Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

(2014) Matthew W. Sherwood et al.   CIRCULATION

‘New’ direct oral anticoagulants in the perioperative setting

(2014) Georg Breuer et al.   Current Opinion in Anesthesiology

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

(2014) J. Beyer-Westendorf et al.   EUROPEAN HEART JOURNAL

Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial

(2014) S. Schulman et al.   THROMBOSIS RESEARCH

Anticoagulation Management in the Perioperative Phase of Implantable Cardioverter Defibrillator Implantation

(2013) Hisashi Yokoshiki et al.   CIRCULATION JOURNAL

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

(2013) David H. Birnie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch

(2012) S. Schulman et al.   BLOOD

Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines

(2012) Gordon H. Guyatt et al.   CHEST

Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists

(2012) Deborah Siegal et al.   CIRCULATION

Periprocedural Bridging Management of Anticoagulation

(2012) Waldemar E. Wysokinski et al.   CIRCULATION

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

(2012) Jeff S. Healey et al.   CIRCULATION

Periprocedural Anticoagulation Management of Patients With Nonvalvular Atrial Fibrillation

(2012) Waldemar E. Wysokinski et al.   MAYO CLINIC PROCEEDINGS

No Increased Bleeding Events with Continuation of Oral Anticoagulation Therapy for Patients Undergoing Cardiac Device Procedure

(2011) HUNG-KEI LI et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Periprocedural Anticoagulation Management of Patients With Venous Thromboembolism

(2010) Robert D. McBane et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation

(2010) Imdad Ahmed et al.   HEART RHYTHM

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial

(2010) Alan Cheng et al.   HEART RHYTHM

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low–molecular weight heparin

(2009) Alex Tischenko et al.   AMERICAN HEART JOURNAL

Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial

(2009) J. M. Tolosana et al.   EUROPEAN HEART JOURNAL

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Randomized, Prospective Trial Comparing Bridging Therapy Using Low-Molecular-Weight Heparin With Maintenance of Oral Anticoagulation During Extraction of Teeth

(2009) Branislav V. Bajkin et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients

(2009) Paul R. Daniels et al.   THROMBOSIS RESEARCH

Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy

(2008) David A. Garcia   ARCHIVES OF INTERNAL MEDICINE